34 POSTER A phase II study of the combination of bevacizumab and erlotinib in patients with patients with unresectable hepatocellular carcinoma

M.Thomas; M.Lwasaki; K.Higginbotham; R.Lozano; K.Glover; J.Abbruzzese

首页> 外文期刊>European Journal of Cancer Supplements >34 POSTER A phase II study of the combination of bevacizumab and erlotinib in patients with patients with unresectable hepatocellular carcinoma

【24h】

34 POSTER A phase II study of the combination of bevacizumab and erlotinib in patients with patients with unresectable hepatocellular carcinoma

机译：34 POSTER A贝伐珠单抗和厄洛替尼联合治疗无法切除的肝细胞癌患者的II期研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第12期|共2页
作者
M.Thomas; M.Lwasaki; K.Higginbotham; R.Lozano; K.Glover; J.Abbruzzese;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study. [J] . Lubner SJ, Mahoney MR, Kolesar JL, Journal of Clinical Oncology . 2010,第21期

机译：一项多中心的II期临床试验报告：对不可切除的胆道癌患者每两周一次贝伐单抗和厄洛替尼联合治疗：
2. A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma [J] . Melanie?B. Thomas, Elizabeth Garrett-Mayer, Munazza Anis, Oncology: International Journal of Cancer Research and Treatment . 2018,第6期

机译：随机阶段II开放标签多机构研究Bevacizumab和Erlotinib的组合与索拉酮在先进的肝细胞癌患者的一线治疗中相比
3. Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. [J] . Thomas MB, Morris JS, Chadha R, Journal of Clinical Oncology . 2009,第6期

机译：贝伐单抗和厄洛替尼联合治疗晚期肝细胞癌的II期临床试验。
4. Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreatic carcinoma in patients with primary sclerosing cholangitis: epidemiology and risk factors [C] . U. BROOME, A. BERGQUIST Falk Liver Week . 2004

机译：肝细胞癌，胆管癌，结肠癌和初级硬化性胆管炎患者的胰腺癌：流行病学和风险因素
5. Capture and Analysis of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma---Analysis of a Pilot Study [D] . Dong, Cheng. 2014

机译：肝细胞癌患者循环肿瘤细胞的捕获和分析---一项初步研究分析
6. Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study [O] . Sam J. Lubner, Michelle R. Mahoney, Jill L. Kolesar, -1

机译：多中心II期临床试验报告：不可切除的胆道癌患者每两周一次贝伐单抗和每日厄洛替尼联合治疗：II期联合体研究
7. Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study [O] . Lubner, Sam J., Mahoney, Michelle R., Kolesar, Jill L., 2010

机译：多中心II期临床试验报告：不可切除的胆道癌患者每两周一次贝伐单抗和每日厄洛替尼联合治疗：II期联合体研究

34 POSTER A phase II study of the combination of bevacizumab and erlotinib in patients with patients with unresectable hepatocellular carcinoma

著录项

相似文献

相关主题

期刊订阅